Methotrexate
Methotrexate is an active ingredient in 20 FDA-listed drug products sold under 4 names.
Drugs containing Methotrexate
- Methotrexate 11
- Otrexup 7
- Jylamvo 1
- Xatmep 1
Products and strengths
| NDC | Product | Strength | Labeler |
|---|---|---|---|
| 81927-204 | Jylamvo Solution | 2 mg/mL | SHORLA ONCOLOGY INC. |
| 16729-277 | Methotrexate Injection | 25 mg/mL | Accord Healthcare, Inc. |
| 50268-554 | Methotrexate Tablet | 2.5 mg/1 | AvPAK |
| 0143-9517 | Methotrexate Solution | 25 mg/mL | Hikma Pharmaceuticals USA Inc. |
| 0143-9519 | Methotrexate Solution | 25 mg/mL | Hikma Pharmaceuticals USA Inc. |
| 0143-9830 | Methotrexate Injection, Powder, Lyophilized, For Solution | 1 g/1 | Hikma Pharmaceuticals USA Inc. |
| 0143-9518 | Methotrexate Solution | 25 mg/mL | Hikma Pharmaceuticals USA Inc. |
| 0143-9516 | Methotrexate Solution | 25 mg/mL | Hikma Pharmaceuticals USA Inc. |
| 0143-9367 | Methotrexate Injection, Powder, Lyophilized, For Solution | 1 g/1 | Hikma Pharmaceuticals USA Inc. |
| 0904-7141 | Methotrexate Tablet | 2.5 mg/1 | Major Pharmaceuticals |
| 70771-1058 | Methotrexate Tablet | 2.5 mg/1 | Zydus Lifesciences Limited |
| 68382-775 | Methotrexate Tablet | 2.5 mg/1 | Zydus Pharmaceuticals USA Inc. |
| 54436-020 | Otrexup Injection, Solution | 20 mg/.4mL | Antares Pharma, Inc. |
| 54436-025 | Otrexup Injection, Solution | 25 mg/.4mL | Antares Pharma, Inc. |
| 54436-010 | Otrexup Injection, Solution | 10 mg/.4mL | Antares Pharma, Inc. |
| 54436-017 | Otrexup Injection, Solution | 17.5 mg/.4mL | Antares Pharma, Inc. |
| 54436-012 | Otrexup Injection, Solution | 12.5 mg/.4mL | Antares Pharma, Inc. |
| 54436-015 | Otrexup Injection, Solution | 15 mg/.4mL | Antares Pharma, Inc. |
| 54436-022 | Otrexup Injection, Solution | 22.5 mg/.4mL | Antares Pharma, Inc. |
| 52652-2001 | Xatmep Solution | 2.5 mg/mL | Azurity Pharmaceuticals, Inc. |